Economic analysis of childhood pneumonia in Northern Pakistan

Health Policy and Planning

Volumn 23, Issue 6, 2008, Pages 438-442

  Hussain, Hamidah ^a   Waters, Hugh ^a   Khan, Aamir J ^a,b   Omer, Saad B ^a   Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Maternal and Child Health   (Pakistan)

Author keywords

Childhood pneumonia; Cost; Pakistan

Indexed keywords

ARTICLE; CHILDHOOD; CONSULTATION; DISEASE DURATION; DISEASE SEVERITY; DRUG COST; ECONOMIC EVALUATION; FEVER; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; MENINGITIS; PAKISTAN; PATIENT TRANSPORT; PNEUMONIA; PRESCHOOL CHILD; QUESTIONNAIRE; SEPSIS; SOCIOECONOMICS;

CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; HEALTH EXPENDITURES; HUMANS; INFANT; INFANT, NEWBORN; PAKISTAN; PNEUMONIA; PREVENTIVE MEDICINE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 54249111370     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czn033     Document Type: Article

References (22)

1. Advance Market Commitment for Vaccines (AMCV). 2007. Five nations and the Bill & Melinda Gates Foundation launch Advance Market Commitment for vaccines to combat deadly disease in poor nations. Online at: http://www.vaccineamc.org/media/launch_event_01.html, accessed 20 March 2007.
2. Black S, Lieu TA, Thomas RG, Capra A, Shinefield HR. 2001. Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine 19: S83-S86.
3. Brinsmead R, Hill S, Walker D. 2004. Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines. Pediatric Infectious Disease Journal 23: 32-7.
4. Bryce J, Boschi-Pinto C, Shibuya K et al. 2005a. WHO estimates of the causes of death in children. The Lancet 365: 1147-52.
5. Bryce J, Black RE, Walker N. 2005b. Can the world afford to save the lives of 6 million children each year? The Lancet 365: 2193-200.
6. Cutts FT, Zaman SM, Enwere G et al. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. The Lancet 365: 1139-46.
7. Fendrick AM, Lee JH, LaBarge C, Glick HA. 1999. Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis. Archives of Pediatrics and Adolescent Medicine 153: 126-36.
8. Filmer D, Pritchett LH. 2001. Estimating wealth effects without expenditure data - or tears: an application to educational enrollments in states of India. Demography 38: 115-32.
9. Hazir T, Fox LM, Nisar YB et al. 2008. New Outpatient Short-Course Home Oral Therapy for Severe Pneumonia Study Group. The Lancet 371: 49-56.
10. Hussain H, Waters H, Omer S et al. 2006. The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan. International Journal of Health Planning and Management 21: 229-38.
11. Khan AJ, Hussain H, Omer SB et al. High incidence of pneumonia at high altitudes in Pakistan. Bulletin of the World Health Organization, in press.
12. Levine OS, O'Brien KL, Knoll M et al. 2006. Pneumococcal vaccination in developing countries. The Lancet 368: 644.
13. Nizami SQ, Khan IA, Bhutta ZA, Shah SM. 1996. Awareness of National ARI control program among practitioners in Karachi and their prescribing behavior for fever in children under five years of age. Specialist. The Pakistani Journal of Medical Sciences 12: 165-69.
14. Rudan I, Tomaskovic L, Boschi-Pinto C et al. 2004. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bulletin of the World Health Organization 82: 895-903.
15. Rudan I, Arifeen SE, Black RE et al. 2007. Childhood pneumonia and diarrhoea: setting our priorities right. The Lancet Infectious Diseases 7: 56-61.
16. Swingler G, Fransman D, Hussey G. 2003. Conjugate vaccines for preventing Haemophilus influenzae type b infections. Cochrane Database of Systematic Reviews 4: CD001729.
17. UNICEF. 2008. State of the World's Children. New York: UNICEF. Online at: http://www.unicef.org/sowc08/statistics/statistics.php, accessed 11 February 2008.
18. US Census Bureau. 2007. IDP population pyramid. Pakistan: 2002. Online at: http://www.census.gov/ipc/www/idbpyr.html, accessed 12 February 2008.
19. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. 2002. Estimates of world-wide distribution of child deaths from acute respiratory infections. The Lancet Infectious Diseases 2: 25-32.
20. WHO. 2000. Chapter 3: Cough or difficult breathing. In: Management of the child with a serious infection or severe malnutrition. Geneva: World Health Organization. WHO/FCH/CAH/00.1. Online at: http://whglibdoc.who.int/hq/ 2000/WHOFCHCAH00.1.pdf, accessed 4 August 2008.
21. WHO. 2006. WHO Position Paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiological Record 81: 445-52.
22. World Bank. 2002. World Development Indicators. Washington, DC: The World Bank.